What are the causes of marantic (non‑bacterial thrombotic) endocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Marantic Endocarditis

Marantic endocarditis (non-bacterial thrombotic endocarditis) is primarily caused by advanced malignancy, followed by autoimmune disorders with hypercoagulable states, particularly antiphospholipid antibody syndrome and systemic lupus erythematosus. 1

Primary Etiologic Categories

The European Society of Cardiology classifies marantic endocarditis into four major groups based on underlying pathology 1:

1. Malignancy-Associated (Most Common)

  • Advanced adenocarcinomas account for >75% of all cases 2, 3
  • Pancreatic, lung, gastric, and ovarian cancers are the most frequently implicated malignancies 4, 3
  • Atrial myxoma can directly cause valvular vegetations 2
  • Carcinoid syndrome produces characteristic valvular lesions 2
  • Direct tumor invasion of cardiac structures may occur 2

2. Autoimmune and Connective Tissue Disorders

  • Systemic lupus erythematosus with antiphospholipid antibodies (Libman-Sacks endocarditis) 1
  • Primary or secondary antiphospholipid antibody syndrome 1, 2
  • Behçet disease 2
  • Rheumatoid arthritis 2
  • Polyarteritis nodosa 2

3. Hypercoagulable States

  • Disseminated intravascular coagulation 1
  • Trousseau syndrome (migratory thrombophlebitis with malignancy) 1
  • Inherited thrombophilias in the appropriate clinical context 5

4. Chronic Debilitating Conditions

  • Septicemia (without direct valve infection) 1
  • Severe burns 1
  • Tuberculosis 1
  • Uremia 1
  • AIDS 1

5. Post-Cardiac Surgery

  • Vegetations on suture material following valve replacement 2
  • Other postoperative valvular changes 2

6. Valvular Degenerative Changes

  • Myxomatous degeneration of valve tissue 2
  • Ruptured chordae tendineae 2

Pathophysiologic Mechanism

The underlying mechanism involves endothelial damage from turbulent blood flow, leading to platelet and fibrin deposition that forms sterile vegetations in the setting of a hypercoagulable state 1, 6. Unlike infective endocarditis, these vegetations contain no bacteria and cause no destructive changes to the underlying valve 1.

Key Distinguishing Features from Infective Endocarditis

  • Persistently negative blood cultures despite adequate sampling 1, 2
  • No response to antibiotic therapy 1
  • Vegetations are typically small (<3mm), broad-based, and irregularly shaped 1
  • More friable and prone to embolization than infectious vegetations 1
  • Bilateral valve involvement is more common than in infective endocarditis 1
  • Mitral valve affected more frequently than aortic 1

Clinical Pitfalls to Avoid

  • Do not confuse culture-negative infective endocarditis (due to prior antibiotics or fastidious organisms) with true marantic endocarditis 1, 2
  • Always obtain comprehensive hematologic and coagulation studies to identify the underlying hypercoagulable state 1
  • In patients with recurrent systemic emboli, test for antiphospholipid syndrome with lupus anticoagulant, anticardiolipin antibodies, and anti-β2-glycoprotein 1 antibodies on two occasions 12 weeks apart 1
  • Consider occult malignancy screening in any patient presenting with unexplained valvular vegetations and systemic emboli 4, 3
  • Perform transesophageal echocardiography when clinical suspicion is high, as transthoracic echo may miss small vegetations 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non‑Infective Endocarditis: Evidence‑Based Evaluation and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Nonbacterial thrombotic endocarditis (marantic endocarditis) in cancer patients.

Cardiovascular & hematological disorders drug targets, 2010

Guideline

Pathogenesis of Infective Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.